Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9389)
All Articles published online
|
Publishing Process of This Article
|
Jan 7, 2015 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Lee HJ, Kim JI, Lee JS, Jun EJ, Oh JH, Cheung DY, Chung WC, Kim BW, Kim SS. Concomitant therapy achieved the best eradication rate for |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i1/351.htm |
| Number | Citing Articles |
| 1 |
Sotirios D. Georgopoulos, Elias Xirouchakis, Beatrice Martinez-Gonzales, Evanthia Zampeli, Elias Grivas, Charikleia Spiliadi, Maria Sotiropoulou, Kalliopi Petraki, Kostantinos Zografos, Fotini Laoudi, Dionysios Sgouras, Andreas Mentis, Panagiotis Kasapidis, Spyros Michopoulos. Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area. European Journal of Internal Medicine 2016; 32: 84 doi: 10.1016/j.ejim.2016.04.011
|
| 2 |
Lien-Chieh Lin, Tzu-Herng Hsu, Kuang-Wei Huang, Ka-Wai Tam. Nonbismuth concomitant quadruple therapy for <i>Helicobacter pylori</i> eradication in Chinese regions: A meta-analysis of randomized controlled trials. World Journal of Gastroenterology 2016; 22(23): 5445-5453 doi: 10.3748/wjg.v22.i23.5445
|
| 3 |
Youhua Wang, Rulin Zhao, Ben Wang, Qiaoyun Zhao, Zhen Li, Liya Zhu-ge, Wenzhu Yin, Yong Xie. Sequential versus concomitant therapy for treatment of Helicobacter pylori infection: an updated systematic review and meta-analysis. European Journal of Clinical Pharmacology 2018; 74(1): 1 doi: 10.1007/s00228-017-2347-7
|
| 4 |
Salamata Diallo, Marie Louise Bassène, Marieme Polele Fall, Alia Issa, Mame Aisse Thioubou. Evaluation of Three Helicobacter pylori Eradication Protocols in a Digestive Endoscopy Center in Dakar. Open Journal of Gastroenterology 2021; 11(11): 244 doi: 10.4236/ojgas.2021.1111025
|
| 5 |
Beom Jin Kim, Hyun-Soo Kim, Hyun Joo Song, Il-Kwun Chung, Gwang Ha Kim, Byung-Wook Kim, Ki-Nam Shim, Seong Woo Jeon, Yun Jin Jung, Chang-Hun Yang, Ji Hyun Kim, Tae Ho Kim, Sang Gyun Kim, Woon Geon Shin, Sun Moon Kim, Sok Won Han, Jun Haeng Lee, Kyung Ho Kim, Sue K. Park, Byung-Joo Park, Joongyub Lee, Jae G. Kim. Online Registry for Nationwide Database of Current Trend ofHelicobacter pyloriEradication in Korea: Interim Analysis. Journal of Korean Medical Science 2016; 31(8): 1246 doi: 10.3346/jkms.2016.31.8.1246
|
| 6 |
Hyun Joo Song, Ki-Nam Shim, Byung-Wook Kim. Web Survey of Society Members' Recognition of Guidelines for the Diagnosis and Treatment ofHelicobacter pyloriInfection in Korea, 2013 Revised Edition. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(2): 95 doi: 10.7704/kjhugr.2015.15.2.95
|
| 7 |
Natsuda Aumpan, Varocha Mahachai, Ratha‐korn Vilaichone. Management of Helicobacter pylori infection. JGH Open 2023; 7(1): 3 doi: 10.1002/jgh3.12843
|
| 8 |
Olga P Nyssen, Adrian G McNicholl, Francis Megraud, Vincenzo Savarino, Giuseppina Oderda, Carlo A Fallone, Lori Fischbach, Franco Bazzoli, Javier P Gisbert. Sequential versus standard triple first-line therapy forHelicobacter pylorieradication. Cochrane Database of Systematic Reviews 2016; 2016(6) doi: 10.1002/14651858.CD009034.pub2
|
| 9 |
Huimei Xu, Wancong Wang, Xueni Ma, Rukun Feng, Yujing Su, Long Cheng, Yifan Yang, Dekui Zhang. Comparative efficacy and safety of high-dose dual therapy, bismuth-based quadruple therapy and non-bismuth quadruple therapies for Helicobacter pylori infection: a network meta-analysis. European Journal of Gastroenterology & Hepatology 2021; 33(6): 775 doi: 10.1097/MEG.0000000000001835
|
| 10 |
Jong Kyu Park. Can Hybrid Therapy Be an Alternative to the First-line Regimen for Helicobacter pylori Infection?. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2020; 20(4): 257 doi: 10.7704/kjhugr.2020.0051
|
| 11 |
Joonhwan Kim, Kyungwon Kim, Jun Soo Lee, Su Young Kim, Kyung Oh Kim, Yoon Jae Kim, Kwang an Kwon, Dong Kyun Park, Jun-Won Chung. The Efficacy of Rebamipide or Ecabet Sodium Supplementation for Helicobacter pylori Eradication Therapy Compared with Quadruple (Concomitant) Regimen. The Korean Journal of Gastroenterology 2018; 71(4): 204 doi: 10.4166/kjg.2018.71.4.204
|
| 12 |
Mei-Jyh Chen, Chien-Chuan Chen, Yen-Nien Chen, Chieh-Chang Chen, Yu-Jen Fang, Jaw-Town Lin, Ming-Shiang Wu, Jyh-Ming Liou. Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection. American Journal of Gastroenterology 2018; 113(10): 1444 doi: 10.1038/s41395-018-0217-2
|
| 13 |
Kh. R. Aslanova. SOME RESULTS AND PROSPECTS OF THE STUDY OF HELICOBACTER PYLORI INFECTION. Bulletin of Problems Biology and Medicine 2019; 1(2): 111 doi: 10.29254/2077-4214-2019-1-2-149-111-114
|
| 14 |
Seung Joo Kang, Hye-Kyung Jung, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Eradication Rates of Clarithromycin Triple Therapy in Korea: A Systematic Review and Meta-analysis. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2021; 21(1): 35 doi: 10.7704/kjhugr.2020.0056
|
| 15 |
Seung Young Kim, Sang Woo Lee, Jung Wan Choe, Sung Woo Jung, Jong Jin Hyun, Young Kul Jung, Ja Seol Koo, Hyung Joon Yim. Helicobacter pylori eradication rates of concomitant and sequential therapies in Korea. Helicobacter 2017; 22(6) doi: 10.1111/hel.12441
|
| 16 |
Jae Yong Park, Jae Gyu Kim. NewHelicobacter pyloriEradication Therapies. The Korean Journal of Gastroenterology 2018; 72(5): 237 doi: 10.4166/kjg.2018.72.5.237
|
| 17 |
ROQUE SÁENZ F.. “HELICOBACTER PYLORI, HOY”. UNA HISTORIA DE 30 AÑOS…. Revista Médica Clínica Las Condes 2015; 26(5): 572 doi: 10.1016/j.rmclc.2015.09.004
|
| 18 |
Javier Alcedo, Marta Gracia, Paula García-Cámara, Carmen Palacín, Sonia Gallego, Cristina Jimeno-Ayllon, Santiago Frago, Isabel Aured, Lara Luzón. Prospective comparative study between two first-line regimens for Helicobacter pylori eradication: Non-bismuth quadruple versus bismuth quadruple therapy. Gastroenterología y Hepatología (English Edition) 2020; 43(6): 301 doi: 10.1016/j.gastre.2019.12.002
|
| 19 |
Bo Li, Xiaoqian Lan, Li Wang, Jiani Zhao, Jingli Ding, Hao Ding, Jun Lei, Yiping Wei, Wenxiong Zhang. Proton-pump inhibitor and amoxicillin-based triple therapy containing clarithromycin versus metronidazole for Helicobacter pylori: A meta-analysis. Microbial Pathogenesis 2020; 142: 104075 doi: 10.1016/j.micpath.2020.104075
|
| 20 |
Su Young Kim, Duck Joo Choi, Jun-Won Chung. Antibiotic treatment for <italic>Helicobacter pylori</italic>: Is the end coming?. World Journal of Gastrointestinal Pharmacology and Therapeutics 2015; 6(4): 183-198 doi: 10.4292/wjgpt.v6.i4.183
|
| 21 |
Masaki Murata, Mitsushige Sugimoto, Hitomi Mizuno, Takeshi Kanno, Kiichi Satoh. Clarithromycin Versus Metronidazole in First-Line Helicobacter Pylori Triple Eradication Therapy Based on Resistance to Antimicrobial Agents: Meta-Analysis. Journal of Clinical Medicine 2020; 9(2): 543 doi: 10.3390/jcm9020543
|
| 22 |
Yeon‐Ji Kim, Woo Chul Chung, Dae Bum Kim. Efficacy of bismuth added to standard triple therapy as the first‐line eradication regimen for Helicobacter pylori infection. Helicobacter 2021; 26(3) doi: 10.1111/hel.12792
|
| 23 |
Chung Hyun Tae, Ki-Nam Shim. Current Strategies for Eradication ofHelicobacter pyloriin Korea. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(4): 222 doi: 10.7704/kjhugr.2015.15.4.222
|
| 24 |
Moon Won Lee, Gwang Ha Kim, Sung Yong Han, Young Joo Park, Hye Kyung Jeon, Bong Eun Lee, Geun Am Song. First-lineHelicobacter pyloriEradication with Standard Triple Therapy and Concomitant Therapy: A Retrospective Study. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2018; 18(2): 120 doi: 10.7704/kjhugr.2018.18.2.120
|
| 25 |
Joon Sung Kim. The Optimal Second-line Rescue Therapy after Failure of Non-bismuth Quadruple Treatments. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(2): 145 doi: 10.7704/kjhugr.2015.15.2.145
|
| 26 |
Didem Şen Karaman, Utku Kürşat Ercan, Emel Bakay, Nermin Topaloğlu, Jessica M. Rosenholm. Evolving Technologies and Strategies for Combating Antibacterial Resistance in the Advent of the Postantibiotic Era. Advanced Functional Materials 2020; 30(15) doi: 10.1002/adfm.201908783
|
| 27 |
Da Wit Shin, Dae Young Cheung, Ji Hee Song, Kyungseok Choi, Jihye Lim, Han Hee Lee, Jin Il Kim, Soo-Heon Park. The benefit of the bismuth add-on to the 2-week clarithromycin-based triple regimen for Helicobacter pylori eradication: a propensity score-matched retrospective study. Gut Pathogens 2023; 15(1) doi: 10.1186/s13099-023-00539-y
|
| 28 |
Jun-Hyung Cho, So-Young Jin. Current guidelines for <i>Helicobacter pylori </i>treatment in East Asia 2022: Differences among China, Japan, and South Korea. World Journal of Clinical Cases 2022; 10(19): 6349-6359 doi: 10.12998/wjcc.v10.i19.6349
|
| 29 |
Zohreh Bari, Hafez Fakheri, Tarang Taghvaei, Mohammad Yaghoobi. A Comparison between 10-day and 12-day Concomitant Regimens for Helicobacter Pylori Eradication: A Randomized Clinical Trial. Middle East Journal of Digestive Diseases 2020; 12(2): 106 doi: 10.34172/mejdd.2020.169
|
| 30 |
Sung Min Jung, Dae Young Cheung, Jin Il Kim, Il Kim, Hyeonjin Seong. Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy ofHelicobacter pyloriEradication. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/1293649
|
| 31 |
Keliang Wang, Dandi Lou, Wei Dai, Rongrong Fu, Zhenhua Ma. Comparison of sequential therapy with concomitant therapy in first-line treatment of Helicobacter pylori: an updated meta-analysis.
Journal of Medical Microbiology
2022; 71(1) doi: 10.1099/jmm.0.001490
|
| 32 |
Olga P. Nyssen, Belén Martínez, Francis Mégraud, Vincenzo Savarino, Carlo A. Fallone, Franco Bazzoli, Javier P. Gisbert. Sequential versus Standard Triple Therapy for First-Line Helicobacter pylori Eradication: An Update. Antibiotics 2024; 13(2): 136 doi: 10.3390/antibiotics13020136
|
| 33 |
Endalew Gebeyehu, Desalegn Nigatu, Ephrem Engidawork, Yan Li. Self-reported adverse drug effects and associated factors among H. pylori infected patients on standard triple therapy: Prospective follow up study. PLOS ONE 2019; 14(11): e0225585 doi: 10.1371/journal.pone.0225585
|
| 34 |
Kazunori Nagashima, Keiichi Tominaga, Koh Fukushi, Akira Kanamori, Takako Sasai, Hideyuki Hiraishi. Recent trends in the occurrence of bleeding gastric and duodenal ulcers under the Japanese evidence‐based clinical practice guideline for peptic ulcer disease. JGH Open 2018; 2(6): 255 doi: 10.1002/jgh3.12078
|
| 35 |
Soo Yeon Choi, Na Rae Lim, Woo Chul Chung. Tailored Therapy Using Bismuth Add-on Standard Triple Therapy vs. Concomitant Therapy: A First-line Regimen for Helicobacter pylori Infection. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2023; 23(2): 118 doi: 10.7704/kjhugr.2022.0058
|
| 36 |
Javier Alcedo, Marta Gracia, Paula García-Cámara, Carmen Palacín, Sonia Gallego, Cristina Jimeno-Ayllon, Santiago Frago, Isabel Aured, Lara Luzón. Prospective comparative study between two first-line regimens for Helicobacter pylori eradication: Non-bismuth quadruple versus bismuth quadruple therapy. Gastroenterología y Hepatología 2020; 43(6): 301 doi: 10.1016/j.gastrohep.2019.12.002
|
| 37 |
Jong Yeul Lee, Ji Yong Ahn, Il Ju Choi. Historical Perspective ofHelicobacter pyloriTreatment in Korea. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(4): 211 doi: 10.7704/kjhugr.2015.15.4.211
|
| 38 |
Sanjeev Kumar Jha, Manish K. Mishra, Kuldeep Saharawat, Praveen Jha, Shubham Purkayastha, Ravish Ranjan. Comparison of concomitant therapy versus standard triple-drug therapy for eradication of Helicobacter pylori infection: A prospective open-label randomized controlled trial. Indian Journal of Gastroenterology 2019; 38(4): 325 doi: 10.1007/s12664-019-00949-4
|
| 39 |
Ru-Jia Li, Yuan-Yuan Dai, Chun Qin, Xiao-Hua Li, Yan-Chun Qin, Yong Pan, Yong-Yi Huang, Zan-Song Huang, Yan-Qiang Huang. Treatment strategies and preventive methods for drug-resistant <i>Helicobacter pylori</i> infection. World Journal of Meta-Analysis 2020; 8(2): 98-108 doi: 10.13105/wjma.v8.i2.98
|
| 40 |
Yoon Suk Jung, Chan Hyuk Park, Jung Ho Park, Eunwoo Nam, Hang Lak Lee. Efficacy of Helicobacter pylori eradication therapies in Korea: A systematic review and network meta‐analysis. Helicobacter 2017; 22(4) doi: 10.1111/hel.12389
|
| 41 |
Hyun Jin Bae, Joon Sung Kim, Byung-Wook Kim, Yun Jung Nam. Concomitant or Sequential Therapy as the First-line Therapy for Eradication of Helicobacter pylori Infection in Korea: A Systematic Review and Meta-analysis. The Korean Journal of Gastroenterology 2018; 71(1): 31 doi: 10.4166/kjg.2018.71.1.31
|
| 42 |
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence-based Guidelines for the Treatment of Helicobacter pylori Infection in Korea: 2020 Revised Edition. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2020; 20(4): 261 doi: 10.7704/kjhugr.2020.0045
|
| 43 |
Sho Suzuki, Takuji Gotoda, Chika Kusano, Kunio Iwatsuka, Mitsuhiko Moriyama. The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy. American Journal of Gastroenterology 2016; 111(7): 949 doi: 10.1038/ajg.2016.182
|
| 44 |
Anthony O'Connor, Javier P. Gisbert, Colm O'Morain, Spiros Ladas. Treatment of Helicobacter pylori Infection 2015. Helicobacter 2015; 20(S1): 54 doi: 10.1111/hel.12258
|
| 45 |
|
| 46 |
Amrit K. Kamboj, Thomas G. Cotter, Amy S. Oxentenko. Helicobacter pylori. Mayo Clinic Proceedings 2017; 92(4): 599 doi: 10.1016/j.mayocp.2016.11.017
|
| 47 |
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020. The Korean Journal of Internal Medicine 2021; 36(4): 807 doi: 10.3904/kjim.2020.701
|
| 48 |
Miaomiao Liang, Chengbi Zhu, Peipei Zhao, Xiaohui Zhu, Junwei Shi, Bin Yuan. Comparison of multiple treatment regimens in children with Helicobacter pylori infection: A network meta-analysis. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1068809
|
| 49 |
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence-Based Guidelines for the Treatment of <i>Helicobacter pylori</i> Infection in Korea 2020. Gut and Liver 2021; 15(2): 168 doi: 10.5009/gnl20288
|
| 50 |
Hyuk Lee, Beom Jin Kim, Sang Gyun Kim, Jin Il Kim, Il Ju Choi, Yong Chan Lee, Jae G. Kim, Jae J. Kim. Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial. Trials 2017; 18(1) doi: 10.1186/s13063-017-2281-0
|
| 51 |
Jae Hyun Jung, In Kuk Cho, Chang Hee Lee, Gwan Gyu Song, Ji Hyun Lim. Clinical Outcomes of Standard Triple Therapy Plus Probiotics or Concomitant Therapy for Helicobacter pylori Infection. Gut and Liver 2018; 12(2): 165 doi: 10.5009/gnl17177
|
| 52 |
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea: 2020 Revised Edition. The Korean Journal of Medicine 2021; 96(3): 160 doi: 10.3904/kjm.2021.96.3.160
|
| 53 |
Beom Jin Kim, Hyuk Lee, Yong Chan Lee, Seong Woo Jeon, Gwang Ha Kim, Hyun-Soo Kim, Jae Kyu Sung, Dong Ho Lee, Heung Up Kim, Moo In Park, Il Ju Choi, Soon Man Yoon, Sang Wook Kim, Gwang Ho Baik, Ju Yup Lee, Jin Il Kim, Sang Gyun Kim, Jayoun Kim, Joongyup Lee, Jae Gyu Kim, Jae J. Kim. Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea. Gut and Liver 2019; 13(5): 531 doi: 10.5009/gnl19136
|
| 54 |
Nikola Perkovic, Antonio Mestrovic, Josko Bozic, Mirela Pavicic Ivelja, Jonatan Vukovic, Goran Kardum, Zeljko Sundov, Marija Tonkic, Zeljko Puljiz, Katarina Vukojevic, Ante Tonkic. Randomized Clinical Trial Comparing Concomitant and Tailored Therapy for Eradication of Helicobacter pylori Infection. Journal of Personalized Medicine 2021; 11(6): 534 doi: 10.3390/jpm11060534
|
| 55 |
Yonas Tamene, Shefali P Mody, Kaiser O Sadiq, Yogamba M Shivakumar, Eshwar Burra, Kamran Shahid, Tuheen Sankar Nath. Efficacy of Sequential Therapy as the First-Line Treatment in the Eradication of Helicobacter pylori. Cureus 2023; doi: 10.7759/cureus.45593
|
| 56 |
Kee Don Choi. Current Trends ofHelicobacter pyloriEradication in Korea. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(3): 147 doi: 10.7704/kjhugr.2015.15.3.147
|
| 57 |
Frank J Senatore, Jonathan Wilmot, John W Birk. Helicobacter pyloritreatment: Still a work in progress. Postgraduate Medicine 2016; 128(1): 152 doi: 10.1080/00325481.2016.1103194
|
| 58 |
Yoen‐Young Chuah, Deng‐Chyang Wu, Seng‐Kee Chuah, Jyh‐Chin Yang, Tzong‐Hsi Lee, Hong‐Zen Yeh, Chan‐Lin Chen, Yu‐Hwa Liu, Ping‐I Hsu. Real‐world practice and Expectation of Asia‐Pacific physicians and patients in Helicobacter Pylori eradication (REAP‐HP Survey). Helicobacter 2017; 22(3) doi: 10.1111/hel.12380
|
| 59 |
Yan‐Hong Ji, Yan‐Mei Shi, Qian‐Wen Hei, Jin‐Min Sun, Xiao‐Feng Yang, Tao Wu, Da‐Li Sun, Yu‐Xing Qi. Evaluation of guidelines for diagnosis and treatment of Helicobacter pylori infection. Helicobacter 2023; 28(1) doi: 10.1111/hel.12937
|